MDMA Therapy Progress

Exciting developments in MDMA-assisted psychotherapy for PTSD are underway, with ongoing phase three studies aiming for FDA approval by 2022. The research focuses on trauma's role in various mental health issues, including social anxiety and substance abuse. As the team approaches a critical interim analysis, hopes are high for statistical significance that could pave the way for groundbreaking treatment options.